- Home
- RNA vs ACIW Comparison
RNA vs ACIW Comparison
Compare RNA & ACIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- ACIW
- Stock Information
- Founded
- RNA 2012
- ACIW 1975
- Country
- RNA United States
- ACIW United States
- Employees
- RNA N/A
- ACIW N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- ACIW EDP Services
- Sector
- RNA Health Care
- ACIW Technology
- Exchange
- RNA Nasdaq
- ACIW Nasdaq
- Market Cap
- RNA 4.0B
- ACIW 4.7B
- IPO Year
- RNA 2020
- ACIW 1995
- Fundamental
- Price
- RNA $41.81
- ACIW $51.13
- Analyst Decision
- RNA Strong Buy
- ACIW Strong Buy
- Analyst Count
- RNA 16
- ACIW 3
- Target Price
- RNA $69.81
- ACIW $60.00
- AVG Volume (30 Days)
- RNA 3.7M
- ACIW 876.2K
- Earning Date
- RNA 11-06-2025
- ACIW 11-06-2025
- Dividend Yield
- RNA N/A
- ACIW N/A
- EPS Growth
- RNA N/A
- ACIW 38.68
- EPS
- RNA N/A
- ACIW 2.37
- Revenue
- RNA $10,729,000.00
- ACIW $1,700,613,000.00
- Revenue This Year
- RNA N/A
- ACIW $10.58
- Revenue Next Year
- RNA $109.60
- ACIW $6.98
- P/E Ratio
- RNA N/A
- ACIW $21.56
- Revenue Growth
- RNA 1.23
- ACIW 11.22
- 52 Week Low
- RNA $21.51
- ACIW $40.45
- 52 Week High
- RNA $56.00
- ACIW $59.71
- Technical
- Relative Strength Index (RSI)
- RNA 45.80
- ACIW 64.52
- Support Level
- RNA $39.83
- ACIW $48.83
- Resistance Level
- RNA $42.42
- ACIW $50.94
- Average True Range (ATR)
- RNA 2.92
- ACIW 1.14
- MACD
- RNA -1.12
- ACIW -0.11
- Stochastic Oscillator
- RNA 38.92
- ACIW 84.21
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About ACIW ACI Worldwide Inc.
ACI Worldwide Inc develops, markets and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.